Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000759EBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10003545HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10021683HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10030463HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10040017HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10034647HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10043869HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS44008149HTLV-1ENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TCGA Plot Options
Drug Information
GeneGABRG2
DrugBank IDDB00395
Drug NameCarisoprodol
Target IDBE0003592
UniProt IDP18507
Regulation Type
PubMed IDs19244096; 20419052; 28642232
CitationsGonzalez LA, Gatch MB, Taylor CM, Bell-Horner CL, Forster MJ, Dillon GH: Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies. J Pharmacol Exp Ther. 2009 May;329(2):827-37. doi: 10.1124/jpet.109.151142. Epub 2009 Feb 24.@@Gonzalez LA, Gatch MB, Forster MJ, Dillon GH: Abuse Potential of Soma: the GABA(A) Receptor as a Target. Mol Cell Pharmacol. 2009 Jan 1;1(4):180-186.@@Kumar M, Kumar M, Freund JM, Dillon GH: A Single Amino Acid Residue at Transmembrane Domain 4 of the alpha Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA Receptors. J Pharmacol Exp Ther. 2017 Sep;362(3):395-404. doi: 10.1124/jpet.117.242156. Epub 2017 Jun 22.
GroupsApproved
Direct ClassificationCarbamate esters
SMILESCCCC(C)(COC(N)=O)COC(=O)NC(C)C
Pathways
PharmGKBPA448809
ChEMBLCHEMBL1233